Non-urothelial and urothelial variants of bladder cancer

Siegel, 2022, Cancer statistics, 2022, CA Cancer J. Clin., 72, 7, 10.3322/caac.21708 Dahm, 2003, Malignant non-urothelial neoplasms of the urinary bladder: a review, Eur. Urol., 44, 672, 10.1016/S0302-2838(03)00416-0 Park, 2019, Non-urothelial carcinomas of the bladder, Histopathology, 74, 97, 10.1111/his.13719 Epaillard, 2021, Treatments outcomes in histological variants and non-urothelial bladder cancer: results of a multicenter retrospective study, Front. Oncol., 11, 10.3389/fonc.2021.671969 Helpap, 2001, Nonepithelial neoplasms of the urinary bladder, Virchows. Arch., 439, 497, 10.1007/s004280100479 Aragon-Ching, 2022, Contemporary treatment and survival differences in patients with urothelial versus nonurothelial bladder and upper tract carcinomas: analyses from the National Cancer Database (NCDB), J. Clin. Oncol., 40, 463, 10.1200/JCO.2022.40.6_suppl.463 Humphrey, 2016, The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B: prostate and Bladder Tumours, Eur. Urol., 70, 106, 10.1016/j.eururo.2016.02.028 Black, 2020, Variant histology in bladder cancer: diagnostic and clinical implications, Transl. Cancer Res., 9, 6565, 10.21037/tcr-20-2169 Ravi, 2013, Non urothelial bladder cancers: a case series, Indian J. Surg. Oncol., 4, 2, 10.1007/s13193-012-0176-9 Grilo, 2020, Facing treatment of non-urothelial bladder cancers in the immunotherapy era, Crit. Rev. Oncol. Hematol., 153, 10.1016/j.critrevonc.2020.103034 Johnson, 1976, Squamous cell carcinoma of the bladder, J. Urol., 115, 542, 10.1016/S0022-5347(17)59272-1 Lagwinski, 2007, Squamous cell carcinoma of the bladder: a clinicopathologic analysis of 45 cases, Am. J. Surg. Pathol., 31, 1777, 10.1097/PAS.0b013e31805c9cd9 Rous, 1978, Squamous cell carcinoma of the bladder, J. Urol., 120, 561, 10.1016/S0022-5347(17)57276-6 Felix, 2008, The changing patterns of bladder cancer in Egypt over the past 26 years, Cancer Causes Control., 19, 421, 10.1007/s10552-007-9104-7 Kitinya, 1986, The incidence of squamous and transitional cell carcinomas of the urinary bladder in northern Tanzania in areas of high and low levels of endemic Schistosoma haematobium infection, Trans. R. Soc. Trop. Med. Hyg., 80, 935, 10.1016/0035-9203(86)90264-6 Manunta, 2005, Non-transitional cell bladder carcinomas, BJU Int., 95, 497, 10.1111/j.1464-410X.2005.05327.x Shokeir, 2004, Squamous cell carcinoma of the bladder: pathology, diagnosis and treatment, BJU Int., 93, 216, 10.1111/j.1464-410X.2004.04588.x Rundle, 1982, Squamous cell carcinoma of bladder. A review of 114 patients, Br. J. Urol., 54, 522, 10.1111/j.1464-410X.1982.tb13580.x Gailey, 2013, Immunohistochemistry for the novel markers glypican 3, PAX8, and p40 (DeltaNp63) in squamous cell and urothelial carcinoma, Am. J. Clin. Pathol., 140, 872, 10.1309/AJCP4NSKW5TLGTDS Suo, 1993, Squamous cell carcinomas. An immunohistochemical study of cytokeratins and involucrin in primary and metastatic tumours, Histopathology, 23, 45, 10.1111/j.1365-2559.1993.tb01182.x Amin, 2014, Members of the IIiDUPG. Best practices recommendations in the application of immunohistochemistry in the bladder lesions: report from the International Society of Urologic Pathology consensus conference, Am. J. Surg. Pathol., 38, e20, 10.1097/PAS.0000000000000240 Kalisvaart, 2010, Bladder cancer in spinal cord injury patients, Spinal Cord., 48, 257, 10.1038/sc.2009.118 Manley, 2017, Risk factors for development of primary bladder squamous cell carcinoma, Ann. R. Coll. Surg. Engl., 99, 155, 10.1308/rcsann.2016.0343 Gui-Zhong, 2017, Bladder cancer in individuals with spinal cord injuries: a meta-analysis, Spinal Cord, 55, 341, 10.1038/sc.2016.151 Guo, 2006, Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases, Am. J. Surg. Pathol., 30, 883, 10.1097/01.pas.0000213283.20166.5a Khan, 2002, Keratinising squamous metaplasia of the bladder: natural history and rationalization of management based on review of 54 years experience, Eur. Urol., 42, 469, 10.1016/S0302-2838(02)00358-5 Dotson, 2019, Squamous cell carcinoma of the bladder: poor response to neoadjuvant chemotherapy, Int. J. Clin. Oncol., 24, 706, 10.1007/s10147-019-01409-x Kassouf, 2007, Outcome and patterns of recurrence of nonbilharzial pure squamous cell carcinoma of the bladder: a contemporary review of The University of Texas M D Anderson Cancer Center experience, Cancer, 110, 764, 10.1002/cncr.22853 Royce, 2018, Clinical characteristics and outcomes of nonurothelial cell carcinoma of the bladder: Results from the National Cancer Data Base, Urol. Oncol., 36, 78, 10.1016/j.urolonc.2017.10.013 Matulay, 2019, The impact of squamous histology on survival in patients with muscle-invasive bladder cancer, Urol. Oncol., 37, 353, 10.1016/j.urolonc.2019.01.020 Abol-Enein, 2007, Nonurothelial cancer of the bladder, Urology, 69, 93, 10.1016/j.urology.2006.08.1107 Porter, 2002, Racial variation in the incidence of squamous cell carcinoma of the bladder in the United States, J. Urol., 168, 1960, 10.1016/S0022-5347(05)64272-3 Youssef, 2011, Bilharzial vs non-bilharzial related bladder cancer: pathological characteristics and value of cyclooxygenase-2 expression, BJU Int., 108, 31, 10.1111/j.1464-410X.2010.09854.x Youssef, 2015, Utility of biomarkers in the prediction of oncologic outcome after radical cystectomy for squamous cell carcinoma, J. Urol., 193, 451, 10.1016/j.juro.2014.08.109 Ghoneim, 1997, Radical cystectomy for carcinoma of the bladder: critical evaluation of the results in 1,026 cases, J. Urol., 158, 393, 10.1016/S0022-5347(01)64487-2 Ghoneim, 2008, Radical cystectomy for carcinoma of the bladder: 2,720 consecutive cases 5 years later, J. Urol., 180, 121, 10.1016/j.juro.2008.03.024 Izard, 2015, Outcomes of squamous histology in bladder cancer: a population-based study, Urol. Oncol., 33, 425, 10.1016/j.urolonc.2015.06.011 Hammam, 2015, The clinical significance of HER2 protein amplification/expression in urinary bladder lesion, Arab J. Urol., 13, 146, 10.1016/j.aju.2015.01.004 Necchi, 2020, Comprehensive Assessment of Immuno-oncology Biomarkers in Adenocarcinoma, Urothelial Carcinoma, and Squamous-cell Carcinoma of the Bladder, Eur. Urol., 77, 548, 10.1016/j.eururo.2020.01.003 Bardales, 1998, Urine cytology of primary and secondary urinary bladder adenocarcinoma, Cancer, 84, 335, 10.1002/(SICI)1097-0142(19981225)84:6<335::AID-CNCR4>3.0.CO;2-W Nath, 2016 Roy, 2011, Adenocarcinoma of the urinary bladder, Arch. Pathol. Lab. Med., 135, 1601, 10.5858/arpa.2009-0713-RS Dadhania, 2015, Adenocarcinoma of the urinary bladder, Am. J. Clin. Exp. Urol., 3, 51 Zhong, 2013, Primary adenocarcinoma of the urinary bladder: differential diagnosis and clinical relevance, Arch. Pathol. Lab. Med., 137, 371, 10.5858/arpa.2012-0076-RA Whitworth, 2012, Clear cell adenocarcinoma of the lower urinary tract: cytopathologic characteristics and differential diagnoses, Cancer Cytopathol., 120, 308, 10.1002/cncy.21197 Grignon, 1991, Primary adenocarcinoma of the urinary bladder. A clinicopathologic analysis of 72 cases, Cancer, 67, 2165, 10.1002/1097-0142(19910415)67:8<2165::AID-CNCR2820670827>3.0.CO;2-M Lughezzani, 2010, Adenocarcinoma versus urothelial carcinoma of the urinary bladder: comparison between pathologic stage at radical cystectomy and cancer-specific mortality, Urology, 75, 376, 10.1016/j.urology.2009.10.018 Luzzago, 2020, Survival of contemporary patients with non-metastatic urachal vs. non-urachal adenocarcinoma of the urinary bladder, World J. Urol., 38, 2819, 10.1007/s00345-020-03083-5 Busby, 2006, Upper urinary tract tumors with nontransitional histology: a single-center experience, Urology, 67, 518, 10.1016/j.urology.2005.09.010 Elawdy, 2017, Non-transitional cell carcinoma of the upper urinary tract: a case series among 305 cases at a tertiary urology institute, Urol. Ann., 9, 99, 10.4103/0974-7796.198894 Schubert, 1982, Tubular urachal remnants in adult bladders, J. Urol., 127, 40, 10.1016/S0022-5347(17)53595-8 Gopalan, 2009, Urachal carcinoma: a clinicopathologic analysis of 24 cases with outcome correlation, Am. J. Surg. Pathol., 33, 659, 10.1097/PAS.0b013e31819aa4ae Wheeler, 1954, Adenocarcinoma involving the urinary bladder, Cancer, 7, 119, 10.1002/1097-0142(195401)7:1<119::AID-CNCR2820070113>3.0.CO;2-8 Sheldon, 1984, Malignant urachal lesions, J. Urol., 131, 1, 10.1016/S0022-5347(17)50167-6 Aragon-Ching, 2017, Mucinous signet-ring urachal carcinoma of the bladder: case report and review of the literature, Clin. Genitourin. Cancer, 15, e889, 10.1016/j.clgc.2017.05.015 Das, 2020, Mucinous urachal adenocarcinoma: a potential nonfluorodeoxyglucose-avid pitfall on (18)fluorine-fluorodeoxyglucose positron emission tomography/computed tomography, World J. Nucl. Med., 19, 432, 10.4103/wjnm.WJNM_60_19 Siefker-Radtke, 2012, Urachal adenocarcinoma: a clinician's guide for treatment, Semin. Oncol., 39, 619, 10.1053/j.seminoncol.2012.08.011 Blomjous, 1989, Small cell carcinoma of the urinary bladder. A clinicopathologic, morphometric, immunohistochemical, and ultrastructural study of 18 cases, Cancer, 64, 1347, 10.1002/1097-0142(19890915)64:6<1347::AID-CNCR2820640629>3.0.CO;2-Q Trias, 2001, Small cell carcinoma of the urinary bladder. Presentation of 23 cases and review of 134 published cases, Eur. Urol., 39, 85, 10.1159/000052417 Abbas, 1995, Small cell carcinoma of the bladder and prostate, Urology, 46, 617, 10.1016/S0090-4295(99)80290-8 Naturale, 2006, Small cell carcinoma of the bladder, J. Urol., 176, 781, 10.1016/j.juro.2006.05.021 Abrahams, 2005, Small cell carcinoma of the bladder: a contemporary clinicopathological study of 51 cases, Histopathology, 46, 57, 10.1111/j.1365-2559.2004.01980.x Mills, 1987, Small cell undifferentiated carcinoma of the urinary bladder. A light-microscopic, immunocytochemical, and ultrastructural study of 12 cases, Am. J. Surg. Pathol., 11, 606, 10.1097/00000478-198708000-00004 Bezerra, 2014, GATA3 expression in small cell carcinoma of bladder and prostate and its potential role in determining primary tumor origin, Hum. Pathol., 45, 1682, 10.1016/j.humpath.2014.04.011 Jones, 2005, Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder: an immunohistochemical profile of 44 cases, Hum. Pathol., 36, 718, 10.1016/j.humpath.2005.04.007 Sved, 2004, Small cell carcinoma of the bladder, BJU Int., 94, 12, 10.1111/j.1464-410X.2003.04893.x Alijo Serrano, 2007, Large cell and small cell neuroendocrine bladder carcinoma: immunohistochemical and outcome study in a single institution, Am. J. Clin. Pathol., 128, 733, 10.1309/HTREM6QYQDYGNWYA Shen, 2018, Comprehensive genomic profiling of neuroendocrine bladder cancer pinpoints molecular origin and potential therapeutics, Oncogene, 37, 3039, 10.1038/s41388-018-0192-5 Pal, 2017, Comprehensive genomic profiling of relapsed and refractory small cell neuroendocrine carcinoma of the urinary bladder, J. Clin. Oncol., 35, 350, 10.1200/JCO.2017.35.6_suppl.350 Hoffman-Censits, 2021, Urothelial cancers with small cell variant histology have confirmed high tumor mutational burden, frequent TP53 and RB mutations, and a unique gene expression profile, Eur. Urol. Oncol., 4, 297, 10.1016/j.euo.2019.12.002 Necchi, 2021, 710P Comprehensive genomic profiling (CGP) of small cell neuroendocrine carcinoma of the bladder (NEBC), Ann. Oncol., 32, S718, 10.1016/j.annonc.2021.08.106 Russo, 1992, Adult urological sarcoma, J. Urol., 147, 1032, 10.1016/S0022-5347(17)37456-6 Labanaris, 2008, Urinary bladder leiomyosarcoma in adults, Int. Urol. Nephrol., 40, 311, 10.1007/s11255-007-9288-5 Engel, 1998, Angiosarcoma of the bladder: a review, Urology, 52, 778, 10.1016/S0090-4295(98)00286-6 Matoso, 2015, Epithelioid Angiosarcoma of the Bladder: a Series of 9 Cases, Am. J. Surg. Pathol., 39, 1377, 10.1097/PAS.0000000000000444 Nizam, 2018, Epithelioid Angiosarcoma of the Bladder: a Case Report and Review of the Literature, Clin. Genitourin Cancer, 16, e1091, 10.1016/j.clgc.2018.07.010 Dotan, 2006, Adult genitourinary sarcoma: the 25-year Memorial Sloan-Kettering experience, J. Urol., 176, 2033, 10.1016/j.juro.2006.07.021 Klaile, 2016, Variant histology in bladder cancer: how it should change the management in non-muscle invasive and muscle invasive disease?, Transl. Androl. Urol., 5, 692, 10.21037/tau.2016.06.13 Al-Ahmadie, 2016, Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer, Nat. Genet., 48, 356, 10.1038/ng.3503 Teo, 2021, Natural history, response to systemic therapy, and genomic landscape of plasmacytoid urothelial carcinoma, Br. J. Cancer, 124, 1214, 10.1038/s41416-020-01244-2 Erck, 2021, Plasmacytoid variant of urothelial carcinoma: poor prognostic variant with high expression of CDH1 Mutation, Uro, 1, 23, 10.3390/uro1010004 Ricardo-Gonzalez, 2012, Plasmacytoid carcinoma of the bladder: a urothelial carcinoma variant with a predilection for intraperitoneal spread, J. Urol., 187, 852, 10.1016/j.juro.2011.10.145 Amin, 1994, Lymphoepithelioma-like carcinoma of the urinary bladder, Am. J. Surg. Pathol., 18, 466, 10.1097/00000478-199405000-00005 Amin, 1994, Micropapillary variant of transitional cell carcinoma of the urinary bladder. Histologic pattern resembling ovarian papillary serous carcinoma, Am. J. Surg. Pathol., 18, 1224, 10.1097/00000478-199412000-00005 Kwon, 2011, Micropapillary variant of urothelial carcinoma, Adv. Urol., 2011, 10.1155/2011/217153 Stern, 1979, Unusual benign bladder tumor of Brunn nest origin, Urology, 14, 288, 10.1016/0090-4295(79)90505-3 Talbert, 1989, Carcinomas of the urinary bladder with deceptively benign-appearing foci. A report of three cases, Am. J. Surg. Pathol., 13, 374, 10.1097/00000478-198905000-00004 Dhall, 2007, Nested variant of urothelial carcinoma, Arch. Pathol. Lab. Med., 131, 1725, 10.5858/2007-131-1725-NVOUC Murphy, 1992, The nested variant of transitional cell carcinoma: a neoplasm resembling proliferation of Brunn's nests, Mod. Pathol., 5, 240 Atilgan, 2013, Carcinosarcoma of the bladder: a case report and review of the literature, Case Rep. Urol., 2013 Cheng, 2011, Sarcomatoid carcinoma of the urinary bladder: the final common pathway of urothelial carcinoma dedifferentiation, Am. J. Surg. Pathol., 35, e34, 10.1097/PAS.0b013e3182159dec Eberhard, 2021, First report on establishment and characterization of a carcinosarcoma tumour cell line model of the bladder, Sci. Rep., 11, 6030, 10.1038/s41598-021-85400-5 Wang, 2010, Clinical features of sarcomatoid carcinoma (carcinosarcoma) of the urinary bladder: analysis of 221 cases, Sarcoma, 2010, 10.1155/2010/454792 Malla, 2016, Sarcomatoid Carcinoma of the Urinary Bladder, Clin. Genitourin Cancer, 14, 366, 10.1016/j.clgc.2016.03.004 Wright, 2007, Differences in survival among patients with sarcomatoid carcinoma, carcinosarcoma and urothelial carcinoma of the bladder, J. Urol., 178, 2302, 10.1016/j.juro.2007.08.038 Zachariadis, 2011, A case report of urinary bladder carcinosarcoma and review of the literature, Case Rep. Urol., 2011 Lopez-Beltran, 1998, Carcinosarcoma and sarcomatoid carcinoma of the bladder: clinicopathological study of 41 cases, J. Urol., 159, 1497, 10.1097/00005392-199805000-00023 Armstrong, 2009, TP53 mutational analysis supports monoclonal origin of biphasic sarcomatoid urothelial carcinoma (carcinosarcoma) of the urinary bladder, Mod. Pathol., 22, 113, 10.1038/modpathol.2008.176 Choi, 2014, Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy, Cancer Cell, 25, 152, 10.1016/j.ccr.2014.01.009 Damrauer, 2014, Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology, Proc. Natl. Acad. Sci. U. S. A., 111, 3110, 10.1073/pnas.1318376111 Robertson, 2017, Comprehensive molecular characterization of muscle-invasive bladder cancer, Cell, 171, 540, 10.1016/j.cell.2017.09.007 Fong, 2020, Update on bladder cancer molecular subtypes, Transl. Androl. Urol., 9, 2881, 10.21037/tau-2019-mibc-12 Anari, 2019, Non-urothelial bladder cancer: genomic alterations and patient outcomes, J. Clin. Oncol., 37, 399, 10.1200/JCO.2019.37.7_suppl.399 Al-Ezzi, 2021, Genomic characterization of non-schistosomiasis-related squamous cell carcinoma of the urinary bladder: A retrospective exploratory study, PLoS One, 16, 10.1371/journal.pone.0259272 Roy, 2017, Next-generation sequencing-based molecular characterization of primary urinary bladder adenocarcinoma, Mod. Pathol., 30, 1133, 10.1038/modpathol.2017.33 Hoffman-Censits, 2021, Expression of Nectin-4 in Bladder Urothelial Carcinoma, in Morphologic Variants, and Nonurothelial Histotypes, Appl. Immunohistochem. Mol. Morphol., 29, 619, 10.1097/PAI.0000000000000938 Guo, 2016, Gene expression profile of the clinically aggressive micropapillary variant of bladder cancer, Eur. Urol., 70, 611, 10.1016/j.eururo.2016.02.056 Zinnall, 2018, Micropapillary urothelial carcinoma: evaluation of HER2 status and immunohistochemical characterization of the molecular subtype, Hum. Pathol., 80, 55, 10.1016/j.humpath.2018.05.022